Tilray Inc (NASDAQ:TLRY) Shares Sold by Mackenzie Financial Corp

Mackenzie Financial Corp decreased its stake in shares of Tilray Inc (NASDAQ:TLRY) by 71.0% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 59,900 shares of the company’s stock after selling 146,614 shares during the quarter. Mackenzie Financial Corp’s holdings in Tilray were worth $99,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of Montreal Can raised its holdings in shares of Tilray by 19.6% during the 2nd quarter. Bank of Montreal Can now owns 2,169,100 shares of the company’s stock worth $3,622,000 after acquiring an additional 355,778 shares during the period. Lazard Asset Management LLC purchased a new position in Tilray during the first quarter worth about $118,000. Avantax Advisory Services Inc. boosted its holdings in Tilray by 46.2% in the 1st quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock valued at $131,000 after purchasing an additional 16,792 shares during the last quarter. Concurrent Investment Advisors LLC purchased a new stake in shares of Tilray in the 1st quarter valued at approximately $75,000. Finally, CIBC Asset Management Inc increased its holdings in shares of Tilray by 13.3% during the 2nd quarter. CIBC Asset Management Inc now owns 871,299 shares of the company’s stock worth $1,445,000 after buying an additional 102,316 shares during the last quarter. Institutional investors and hedge funds own 9.35% of the company’s stock.

Tilray Price Performance

TLRY stock opened at $1.65 on Tuesday. Tilray Inc has a 52-week low of $1.50 and a 52-week high of $2.97. The company has a quick ratio of 1.42, a current ratio of 2.27 and a debt-to-equity ratio of 0.10. The stock has a market cap of $1.28 billion, a price-to-earnings ratio of -3.75 and a beta of 2.13. The business has a fifty day moving average of $1.78 and a two-hundred day moving average of $1.87.

Tilray (NASDAQ:TLRY) last issued its quarterly earnings data on Monday, July 29th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.02) by ($0.02). Tilray had a negative return on equity of 2.63% and a negative net margin of 30.26%. The business had revenue of $229.90 million for the quarter, compared to analyst estimates of $226.20 million. During the same period in the previous year, the business posted ($0.15) earnings per share. The firm’s revenue for the quarter was up 24.8% compared to the same quarter last year. As a group, research analysts anticipate that Tilray Inc will post -0.16 earnings per share for the current year.

About Tilray

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.